Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique

被引:162
作者
Lamprecht, A
Ubrich, N
Pérez, MH
Lehr, CM
Hoffman, M
Maincent, P
机构
[1] Fac Pharm, Lab Pharm Galen & Biopharm, F-54001 Nancy, France
[2] Univ Saarlandes, Inst Biopharm & Pharmazeut Technol, D-66123 Saarbrucken, Germany
关键词
nanoparticles; encapsulation; double emulsion technique; poly[lactic-co-glycolic acid; poly[epsilon-caprolactone; BSA;
D O I
10.1016/S0378-5173(99)00422-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The preparation of nanoparticles (NP) as an improved colloidal carrier system for proteins was investigated. Bovine serum albumin (BSA) was used as model drug. Owing to the high solubility of the protein in water, the double emulsion technique has been chosen as one of the most appropriate method. In order to both reaching submicron size as well as increasing the grade of monodispersity compared to previous preparation techniques, a microfluidizer as homogenization device was used. All experiments were performed using two biodegradable polymers, poly[D,L-lactic-co-glycolic acid] 50/50 (PLGA) and poly[epsilon-caprolactone] (PCL). The homogenization procedure has been optimized with regard to particle size and monodispersity by studying the influence of the homogenization time as well as the amount of polymer and surfactant in the external aqueous phase. The drug loading has been improved by varying the concentration of the protein in the inner aqueous phase. By increasing the protein concentration in the inner aqueous phase the polydispersity was slightly higher, while the particle size was not influenced significantly. The BSA encapsulation efficiency decreased with higher protein concentration in the inner aqueous phase. All release profiles were characterized by a initial burst effect, a higher release rate was obtained after 4 weeks for PLGA NP (60%) compared with PCL NP (47%). (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:177 / 182
页数:6
相关论文
共 10 条
[1]   ENCAPSULATION OF WATER-SOLUBLE DRUGS BY A MODIFIED SOLVENT EVAPORATION METHOD .1. EFFECT OF PROCESS AND FORMULATION VARIABLES ON DRUG ENTRAPMENT [J].
ALEX, R ;
BODMEIER, R .
JOURNAL OF MICROENCAPSULATION, 1990, 7 (03) :347-355
[2]   Human serum albumin as a probe for protein adsorption to nanoparticles: Relevance to biodistribution [J].
Armstrong, TI ;
Davies, MC ;
Illum, L .
JOURNAL OF DRUG TARGETING, 1997, 4 (06) :389-398
[3]   Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres [J].
Blanco, MD ;
Alonso, MJ .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1997, 43 (03) :287-294
[4]   CONTROLLED DELIVERY SYSTEMS FOR PROTEINS BASED ON POLY(LACTIC GLYCOLIC ACID) MICROSPHERES [J].
COHEN, S ;
YOSHIOKA, T ;
LUCARELLI, M ;
HWANG, LH ;
LANGER, R .
PHARMACEUTICAL RESEARCH, 1991, 8 (06) :713-720
[5]   Polymeric nanoparticles as delivery system for influenza virus glycoproteins [J].
Lemoine, D ;
Preat, V .
JOURNAL OF CONTROLLED RELEASE, 1998, 54 (01) :15-27
[6]   Pharmacokinetics and biodistribution of oligonucleotide adsorbed onto poly(isobutylcyanoacrylate) nanoparticles after intravenous administration in mice [J].
Nakada, Y ;
Fattal, E ;
Foulquier, M ;
Couvreur, P .
PHARMACEUTICAL RESEARCH, 1996, 13 (01) :38-43
[7]  
OGAWA Y, 1988, CHEM PHARM BULL, V36, P1095
[9]   A FORMULATION METHOD USING D,L-LACTIC ACID OLIGOMER FOR PROTEIN RELEASE WITH REDUCED INITIAL BURST [J].
TABATA, Y ;
TAKEBAYASHI, Y ;
UEDA, T ;
IKADA, Y .
JOURNAL OF CONTROLLED RELEASE, 1993, 23 (01) :55-64
[10]   Stealth PLA-PEG nanoparticles as protein carriers for nasal administration [J].
Tobío, M ;
Gref, R ;
Sánchez, A ;
Langer, R ;
Alonso, MJ .
PHARMACEUTICAL RESEARCH, 1998, 15 (02) :270-275